Mustang Bio (MBIO) Current Leases (2019 - 2024)
Mustang Bio's (MBIO) quarterly Current Leases came in at $456000.0 in Q4 2024, down 12.31% year-over-year from $520000.0 in Q1 2024, and up 3.17% quarter-over-quarter from $442000.0 in Q3 2024.
Powered by 
Analysis
Mustang Bio (MBIO) Current Leases (2019 - 2024) Analysis & Trends
Mustang Bio (MBIO) has reported Current Leases for 6 consecutive years, with $456000.0 the latest figure, recorded in Q4 2024.
- On a quarterly basis, Current Leases fell 12.31% year-over-year to $456000.0 in Q4 2024; TTM through Dec 2024 was $456000.0, a 12.31% decrease from a year earlier, with the FY2024 full-year figure at $456000.0, down 12.31% from the prior year.
- Current Leases was $456000.0 for Q4 2024 at Mustang Bio, up from $442000.0 in the prior quarter.
- Over five years, Current Leases peaked at $629000.0 in Q1 2023 and troughed at $257000.0 in Q1 2020.
- A 5-year average of $410950.0 and a median of $388500.0 in 2022 frame the typical range for Current Leases.
- Across the five-year window, Current Leases soared 159.6% in 2020 and decreased 23.87% in 2023, its largest moves.
- Over 5 years, Current Leases stood at $278000.0 in 2020, then gained by 25.18% to $348000.0 in 2021, then surged by 75.86% to $612000.0 in 2022, then decreased by 15.03% to $520000.0 in 2023, then decreased by 12.31% to $456000.0 in 2024.
- The last three Current Leases figures came in at $456000.0 (Q4 2024), $442000.0 (Q3 2024), and $429000.0 (Q2 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.21 Bn | 9.36 Bn | 112.79 Mn | 1.81 Mn |
| 2 | CRISPR Therapeutics AG | 5.03 Bn | 5.03 Bn | - | 18.65 Mn |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.35 Bn | 55.72 Mn | 2.67 Mn |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | - |
| 5 | uniQure | 2.98 Bn | 2.98 Bn | 5.49 Mn | 2.99 Mn |
| 6 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | 15.21 Mn |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | 1.06 Mn |
| 8 | Sarepta Therapeutics | 2.14 Bn | 1.35 Bn | 251.87 Mn | - |
| 9 | Vericel | 1.93 Bn | 1.77 Bn | 56.40 Mn | 14.16 Mn |
| 10 | Mustang Bio | 3.52 Mn | 3.52 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 456,000.00 |
| Sep 30, 2024 | 442,000.00 |
| Jun 30, 2024 | 429,000.00 |
| Mar 31, 2024 | 570,000.00 |
| Dec 31, 2023 | 520,000.00 |
| Sep 30, 2023 | 453,000.00 |
| Jun 30, 2023 | 409,000.00 |
| Mar 31, 2023 | 629,000.00 |
| Dec 31, 2022 | 612,000.00 |
| Sep 30, 2022 | 595,000.00 |
| Jun 30, 2022 | 368,000.00 |
| Mar 31, 2022 | 358,000.00 |
| Dec 31, 2021 | 348,000.00 |
| Sep 30, 2021 | 329,000.00 |
| Jun 30, 2021 | 346,000.00 |
| Mar 31, 2021 | 284,000.00 |
| Dec 31, 2020 | 278,000.00 |
| Sep 30, 2020 | 271,000.00 |
| Jun 30, 2020 | 265,000.00 |
| Mar 31, 2020 | 257,000.00 |